IL157593A0 - Carbamate compounds for use in the treatment of pain - Google Patents

Carbamate compounds for use in the treatment of pain

Info

Publication number
IL157593A0
IL157593A0 IL15759302A IL15759302A IL157593A0 IL 157593 A0 IL157593 A0 IL 157593A0 IL 15759302 A IL15759302 A IL 15759302A IL 15759302 A IL15759302 A IL 15759302A IL 157593 A0 IL157593 A0 IL 157593A0
Authority
IL
Israel
Prior art keywords
pain
treatment
carbamate compounds
carbamate
compounds
Prior art date
Application number
IL15759302A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of IL157593A0 publication Critical patent/IL157593A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL15759302A 2001-02-27 2002-02-21 Carbamate compounds for use in the treatment of pain IL157593A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27188801P 2001-02-27 2001-02-27
PCT/US2002/005421 WO2002067922A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in the treatment of pain

Publications (1)

Publication Number Publication Date
IL157593A0 true IL157593A0 (en) 2004-03-28

Family

ID=23037511

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15759302A IL157593A0 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in the treatment of pain

Country Status (28)

Country Link
US (1) US6815464B2 (zh)
EP (1) EP1404312B1 (zh)
JP (1) JP4276838B2 (zh)
KR (1) KR100906315B1 (zh)
CN (1) CN1849116A (zh)
AR (1) AR033427A1 (zh)
AT (1) ATE493125T1 (zh)
AU (1) AU2002254015B2 (zh)
BR (1) BR0207673A (zh)
CA (1) CA2439274C (zh)
CY (1) CY1111349T1 (zh)
CZ (1) CZ20032298A3 (zh)
DE (1) DE60238765D1 (zh)
DK (1) DK1404312T3 (zh)
ES (1) ES2356617T3 (zh)
HU (1) HUP0303236A3 (zh)
IL (1) IL157593A0 (zh)
MX (1) MXPA03007721A (zh)
MY (1) MY129312A (zh)
NO (1) NO20033804L (zh)
NZ (1) NZ527994A (zh)
PL (1) PL364647A1 (zh)
PT (1) PT1404312E (zh)
RS (1) RS67603A (zh)
RU (1) RU2283106C2 (zh)
TW (1) TWI304735B (zh)
WO (1) WO2002067922A1 (zh)
ZA (1) ZA200307475B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1408954B1 (en) 2001-07-16 2009-07-01 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain
PA8720901A1 (es) * 2006-03-24 2008-11-19 Wyeth Corp Tratamiento del dolor
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
US8927602B2 (en) 2009-11-06 2015-01-06 Sk Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
CN102762201B (zh) 2009-11-06 2013-12-18 爱思开生物制药株式会社 注意力缺陷/多动症的治疗方法
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN102266317A (zh) * 2011-06-24 2011-12-07 中国人民解放军第三军医大学 丙戊酸及其衍生物的应用
JP2015504054A (ja) 2011-12-27 2015-02-05 バイオ−ファーム ソリューションズ カンパニー リミテッド 多発性硬化症の治療または予防に使用されるフェニルカルバメート化合物
CN109939092B (zh) 2013-03-12 2022-03-22 比皮艾思药物研发有限公司 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物
KR102421013B1 (ko) * 2016-05-19 2022-07-14 에스케이바이오팜 주식회사 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
GB2340074A (en) * 1998-08-01 2000-02-16 Max Imaging Systems Limited Printing process
PT1305082E (pt) * 2000-07-21 2004-09-30 Ortho Mcneil Pharm Inc Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca

Also Published As

Publication number Publication date
KR100906315B1 (ko) 2009-07-07
CA2439274A1 (en) 2002-09-06
CA2439274C (en) 2011-04-05
ES2356617T3 (es) 2011-04-11
MY129312A (en) 2007-03-30
RS67603A (en) 2007-02-05
ATE493125T1 (de) 2011-01-15
WO2002067922A1 (en) 2002-09-06
RU2283106C2 (ru) 2006-09-10
HUP0303236A3 (en) 2012-07-30
NO20033804D0 (no) 2003-08-26
JP4276838B2 (ja) 2009-06-10
JP2004523553A (ja) 2004-08-05
AR033427A1 (es) 2003-12-17
TWI304735B (en) 2009-01-01
RU2003128984A (ru) 2005-03-20
CZ20032298A3 (cs) 2004-08-18
NO20033804L (no) 2003-09-30
PT1404312E (pt) 2011-02-01
ZA200307475B (en) 2005-01-03
BR0207673A (pt) 2004-12-28
PL364647A1 (en) 2004-12-13
NZ527994A (en) 2005-11-25
HUP0303236A2 (hu) 2004-01-28
KR20030076711A (ko) 2003-09-26
DK1404312T3 (da) 2011-03-14
DE60238765D1 (de) 2011-02-10
US6815464B2 (en) 2004-11-09
MXPA03007721A (es) 2004-11-12
EP1404312B1 (en) 2010-12-29
CY1111349T1 (el) 2015-08-05
AU2002254015B2 (en) 2006-08-24
EP1404312A1 (en) 2004-04-07
CN1849116A (zh) 2006-10-18
US20020156127A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
IL172418A0 (en) Therapeutic agents useful for treating pain
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL157593A0 (en) Carbamate compounds for use in the treatment of pain
GB0108671D0 (en) Skin treatment
GB0213869D0 (en) The treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
GB0211295D0 (en) Treatment of pain
GB0119025D0 (en) Compounds and their therapeutic use
IL164951A0 (en) The treatment of pain with lfendropil
GB0106316D0 (en) Apparatus for use in the treatment of hair
GB9904252D0 (en) Composition for the treatment of pain
GB2376943B (en) Compounds and their therapeutic use
GB0112237D0 (en) Compounds and their therapeutic use
GB0211297D0 (en) Pain treatment
IL174968A0 (en) The use of ifenprodil in the treatment of pain
GB0325957D0 (en) The treatment of pain
EP1451308A4 (en) THERAPEUTIC USE OF AZIRIDINO COMPOUNDS
GB0216978D0 (en) The treatment of pain
GB0322014D0 (en) The treatment of pain
EP1372630A4 (en) AGENT FOR THE TREATMENT OF THE HYPERACTIVE BLADDER
GB0119173D0 (en) Pain treatment